BioAge Labs, Inc.
BIOA
$10.49
$1.2713.77%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.82% | -58.77% | 0.49% | -0.82% | -60.05% |
| Total Depreciation and Amortization | 28.95% | 18.37% | 12.12% | 14.63% | -20.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 29.18% | 96.86% | 54.00% | -70.05% | -60.04% |
| Change in Net Operating Assets | -80.31% | 54.61% | -60.26% | 199.96% | 382.65% |
| Cash from Operations | -7.45% | -26.54% | -10.79% | 39.57% | -92.34% |
| Capital Expenditure | 92.79% | -354.29% | -- | -- | -208.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 4,310.16% | -44,588.57% | -- | -- | -208.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | -50.00% | -- |
| Issuance of Common Stock | -- | -- | -- | 691,050.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 97.80% | -- | -- | -9,469.23% | -4,659.52% |
| Cash from Financing | -100.81% | 37.16% | -100.89% | 2,567.99% | 454,107.14% |
| Foreign Exchange rate Adjustments | 82.76% | -170.59% | -163.16% | 310.77% | -265.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -102.71% | -103.93% | -163.58% | 307.53% | 2,328.86% |